BIOMAT Database Logo BIOMAT Database Logo

[Cerebral hemodynamics under the effect of 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride]. 1966

E Deisenhammer, and E M Klausberger

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002560 Cerebrovascular Circulation The circulation of blood through the BLOOD VESSELS of the BRAIN. Brain Blood Flow,Regional Cerebral Blood Flow,Cerebral Blood Flow,Cerebral Circulation,Cerebral Perfusion Pressure,Circulation, Cerebrovascular,Blood Flow, Brain,Blood Flow, Cerebral,Brain Blood Flows,Cerebral Blood Flows,Cerebral Circulations,Cerebral Perfusion Pressures,Circulation, Cerebral,Flow, Brain Blood,Flow, Cerebral Blood,Perfusion Pressure, Cerebral,Pressure, Cerebral Perfusion
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000792 Angiography Radiography of blood vessels after injection of a contrast medium. Arteriography,Angiogram,Angiograms,Angiographies,Arteriographies
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive

Related Publications

E Deisenhammer, and E M Klausberger
[Blood circulation studies with 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride].
March 1967, Arzneimittel-Forschung,
E Deisenhammer, and E M Klausberger
Hyperglycemic action of 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride in relation to its hypertensive effect.
June 1969, Japanese journal of pharmacology,
E Deisenhammer, and E M Klausberger
[Catapresan (2-(2,6-dichlorphenylamino)-2-imidazoline-hydrochloride)--a new intraocular pressure lowering agent].
January 1969, Klinische Monatsblatter fur Augenheilkunde,
E Deisenhammer, and E M Klausberger
[Hemodynamic studies on the long-term therapy with 2-(2,6-dichlorphenylamino)-2-imidazoline-hydrochloride].
June 1970, Das Deutsche Gesundheitswesen,
E Deisenhammer, and E M Klausberger
[Experimental study of kidney hemodynamics and the behavior of electrolytes after a single administration of 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride].
September 1966, Arzneimittel-Forschung,
E Deisenhammer, and E M Klausberger
[Studies on the pharmacokinetics and on the metabolism of 2(2,6-dichlorphenylamino)-2-imidazoline-hydrochloride (St 155)].
February 1969, Arzneimittel-Forschung,
E Deisenhammer, and E M Klausberger
Investigations into the mechanism of the hypotensive effect of 2-(2,6-dichlorphenylamino)-2-imidazoline-HCl.
December 1967, European journal of pharmacology,
E Deisenhammer, and E M Klausberger
Aggressive behavior induced by large doses of 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride (ST 155) in mice.
July 1968, European journal of pharmacology,
E Deisenhammer, and E M Klausberger
[Central effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride].
September 1968, Arzneimittel-Forschung,
E Deisenhammer, and E M Klausberger
[Hypotensive effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride].
June 1970, La Clinica terapeutica,
Copied contents to your clipboard!